| Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice F Guida, F Turco, M Iannotta, D De Gregorio, I Palumbo, G Sarnelli, ... Brain, behavior, and immunity 67, 230-245, 2018 | 107 | 2018 |
| Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice F Guida, L Luongo, F Marmo, R Romano, M Iannotta, F Napolitano, ... Molecular brain 8 (1), 1-15, 2015 | 88 | 2015 |
| Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ... Pain 160 (1), 136, 2019 | 75 | 2019 |
| Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety‐like behavior R Imperatore, G Morello, L Luongo, U Taschler, R Romano, ... Journal of neurochemistry 135 (4), 799-813, 2015 | 51 | 2015 |
| Alterations of brain and cerebellar proteomes linked to A β and tau pathology in a female triple-transgenic murine model of Alzheimer's disease D Ciavardelli, E Silvestri, A Del Viscovo, M Bomba, D De Gregorio, ... Cell death & disease 1 (10), e90-e90, 2010 | 50 | 2010 |
| MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice E Palazzo, R Romano, L Luongo, S Boccella, D De Gregorio, ... Pain 156 (6), 1060-1073, 2015 | 40 | 2015 |
| d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology D De Gregorio, S Comai, L Posa, G Gobbi International journal of molecular sciences 17 (11), 1953, 2016 | 39 | 2016 |
| Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E A Aguilar-Valles, N Haji, D De Gregorio, E Matta-Camacho, ... Nature communications 9 (1), 1-14, 2018 | 31 | 2018 |
| The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors D De Gregorio, L Posa, R Ochoa-Sanchez, R McLaughlin, S Maione, ... Pharmacological Research 113, 81-91, 2016 | 31 | 2016 |
| Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions F Rossi, I Marabese, M De Chiaro, S Boccella, L Luongo, F Guida, ... Journal of neurophysiology 111 (11), 2196-2209, 2014 | 27 | 2014 |
| Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain L Posa, D De Gregorio, G Gobbi, S Comai Current medicinal chemistry 25 (32), 3866-3882, 2018 | 26 | 2018 |
| d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: mechanism of action and potential therapeutic applications in mood disorders D De Gregorio, JP Enns, NA Nuñez, L Posa, G Gobbi Progress in brain research 242, 69-96, 2018 | 26 | 2018 |
| Palmitoylethanolamide reduces neuropsychiatric behaviors by restoring cortical electrophysiological activity in a mouse model of mild traumatic brain injury F Guida, S Boccella, M Iannotta, D De Gregorio, C Giordano, C Belardo, ... Frontiers in Pharmacology 8, 95, 2017 | 24 | 2017 |
| Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice S Maione, L Radanova, D De Gregorio, L Luongo, L De Petrocellis, ... European journal of pharmacology 748, 115-122, 2015 | 22 | 2015 |
| Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain S Boccella, F Guida, F De Logu, D De Gregorio, M Mazzitelli, C Belardo, ... The FASEB Journal 33 (1), 1062-1073, 2019 | 13 | 2019 |
| Melatonin MT1 and MT2 receptors exhibit distinct effects in the modulation of body temperature across the light/dark cycle M López-Canul, SH Min, L Posa, D De Gregorio, A Bedini, G Spadoni, ... International Journal of Molecular Sciences 20 (10), 2452, 2019 | 11 | 2019 |
| Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives S Comai, M Lopez-Canul, D De Gregorio, A Posner, M Ettaoussi, ... Pharmacological Research 144, 343-356, 2019 | 10 | 2019 |
| Characterization of the sensory, affective, cognitive, biochemical, and neuronal alterations in a modified chronic constriction injury model of neuropathic pain in mice P Medeiros, RL de Freitas, S Boccella, M Iannotta, C Belardo, M Mazzitelli, ... Journal of neuroscience research 98 (2), 338-352, 2020 | 9 | 2020 |
| Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor … D De Gregorio, M Manchia, B Carpiniello, F Valtorta, M Nobile, G Gobbi, ... Journal of Affective Disorders 255, 195-200, 2019 | 8 | 2019 |
| Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain F Müller, ME Liechti, UE Lang, S Borgwardt Progress in brain research 242, 159-177, 2018 | 7 | 2018 |
Gabriella GobbiProfessor, McGill University, Montreal, CanadaVerified email at mcgill.ca
